1. Home
  2. VIRT vs BLCO Comparison

VIRT vs BLCO Comparison

Compare VIRT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

N/A

Current Price

$68.72

Market Cap

6.0B

Sector

Finance

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$17.24

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIRT
BLCO
Founded
2008
1853
Country
United States
Canada
Employees
1027
N/A
Industry
Investment Bankers/Brokers/Service
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.4B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
VIRT
BLCO
Price
$68.72
$17.24
Analyst Decision
Hold
Buy
Analyst Count
5
11
Target Price
$45.60
$18.45
AVG Volume (30 Days)
1.3M
403.6K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
1.89%
N/A
EPS Growth
72.73
N/A
EPS
3.62
N/A
Revenue
$3,632,118,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
$1.34
$5.59
P/E Ratio
$16.90
N/A
Revenue Growth
26.25
6.47
52 Week Low
$31.55
$13.77
52 Week High
$68.02
$18.92

Technical Indicators

Market Signals
Indicator
VIRT
BLCO
Relative Strength Index (RSI) 69.40 60.83
Support Level $55.11 $16.26
Resistance Level N/A $17.36
Average True Range (ATR) 3.13 0.43
MACD 0.94 0.04
Stochastic Oscillator 93.92 70.68

Price Performance

Historical Comparison
VIRT
BLCO

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: